Please assess the completion status of the following clinical trial:

Trial Title: Mannitol vs HS to Treat ICHT After Severe TBI : Comparison on PtiO2 and Microdialysis Values

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Severe Traumatic brain injury monitored with ICP, PtiO2 and cerebral microdialysis~* And ICP\> 20 mm Hg needing osmotherapy~* And approval of the next of kind~Exclusion Criteria:~* Bilateral fixed dilated pupils~* Contra-indication to multimodal neuromonitoring~* Previous CNS disease~* Contra-indication to HS (cardiac insufficiency,...)~* Natremia \> 155 mmol/L or osmolarity \> 320 mOsm/L

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Mannitol (Type: ACTIVE_COMPARATOR): None
- Hypertonic saline (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).